Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Luteolin can reduce hair graying in mice, with external treatment being more effective.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

Taking Vitamin D supplements may increase the risk of skin darkening after laser hair removal.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Vitamin D supplements may reduce hair-pulling in people with Trichotillomania.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Localized heat or specific injections can prevent chemotherapy-induced hair loss without affecting cancer treatment.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Human placenta helps hair grow back after chemotherapy by blocking cell death and increasing hair follicle growth.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.